Stock Scorecard



Stock Summary for Brainsway Ltd (BWAY) - $11.93 as of 10/29/2026 8:05:36 PM EST

Total Score

17 out of 30

Safety Score

21 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for BWAY

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for BWAY

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for BWAY

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for BWAY

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for BWAY (21 out of 100)

Stock Price Rating (Max of 10) 5
Historical Stock Price Rating (Max of 10) 2
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 2
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 3
Trading Volume (Max of 10) 4
Price to Earnings (Max of 10) 2
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for BWAY

BrainsWay to Report Third Quarter 2026 Financial Results on November 10, 2026 10/28/2026 12:11:00 PM
Brainsway (BWAY) revises November 25 vote after David Zacut declines re-election for personal reasons. 10/27/2026 6:11:00 AM
BrainsWay expands insurance coverage for OCD treatment to 118M By Investing.com 10/27/2026 2:55:00 AM
BrainsWay expands insurance coverage for OCD treatment to 118M 10/26/2026 12:39:00 PM
BrainsWay OCD treatment now covered for 118 million Americans 10/26/2026 11:39:00 AM
Insurance coverage expands for BrainsWay (BWAY)'s FDA-indicated add-on OCD treatment. 10/26/2026 11:39:00 AM
BrainsWay Expands U.S. Insurance Coverage for Deep TMS™ Treatment of OCD to Over 118 Million Lives 10/26/2026 11:11:00 AM
BrainsWay Ltd. Estimates – NASDAQ:BWAY 10/23/2026 5:09:00 PM
Brainsway Ltd. (BRSYF) stock price, news, quote and history 10/23/2026 1:09:00 AM
BrainsWay Sets November 25, 2026 Annual Shareholder Meeting With Auditor, Board and Equity Votes 10/22/2026 9:09:00 PM

Financial Details for BWAY

Company Overview

Ticker BWAY
Company Name Brainsway Ltd
Country USA
Description Brainsway Ltd., a commercial-stage medical device company, focuses on the development and sale of non-invasive neuromodulation products in Israel and internationally. The company is headquartered in Jerusalem, Israel.
Sector Name HEALTHCARE
Industry Name MEDICAL DEVICES
Most Recent Quarter 6/30/2026
Next Earnings Date 11/10/2026

Stock Price History

Last Day Price 11.93
Price 4 Years Ago 1.24
Last Day Price Updated 10/29/2026 8:05:36 PM EST
Last Day Volume 120,350
Average Daily Volume 103,236
52-Week High 17.40
52-Week Low 7.13
Last Price to 52 Week Low 67.32%

Valuation Measures

Trailing PE 51.68
Industry PE 120.79
Sector PE 57.70
5-Year Average PE 33.10
Free Cash Flow Ratio 7.70
Industry Free Cash Flow Ratio 33.96
Sector Free Cash Flow Ratio 39.66
Current Ratio Most Recent Quarter 3.59
Total Cash Per Share 1.55
Book Value Per Share Most Recent Quarter 1.97
Price to Book Ratio 5.89
Industry Price to Book Ratio 3.92
Sector Price to Book Ratio 37.05
Price to Sales Ratio Twelve Trailing Months 7.54
Industry Price to Sales Ratio Twelve Trailing Months 3.22
Sector Price to Sales Ratio Twelve Trailing Months 20.95
Analyst Buy Ratings 3
Analyst Strong Buy Ratings 0

Share Statistics

Total Shares Outstanding 40,253,000
Market Capitalization 480,218,290
Institutional Ownership 29.44%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 59.80%
Annual Earnings Growth 161.31%
Reported EPS 12 Trailing Months 0.22
Reported EPS Past Year 0.20
Reported EPS Prior Year 0.12
Net Income Twelve Trailing Months 9,545,534
Net Income Past Year 7,633,000
Net Income Prior Year 2,921,000
Quarterly Revenue Growth YOY 35.40%
5-Year Revenue Growth 18.81%
Operating Margin Twelve Trailing Months 14.00%

Balance Sheet

Total Cash Most Recent Quarter 62,358,551
Total Cash Past Year 67,700,000
Total Cash Prior Year 69,345,000
Net Cash Position Most Recent Quarter 62,358,551
Net Cash Position Past Year 67,700,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 0
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 1.00
Total Stockholder Equity Past Year 73,221,000
Total Stockholder Equity Prior Year 62,313,000
Total Stockholder Equity Most Recent Quarter 79,188,430

Free Cash Flow

Free Cash Flow Twelve Trailing Months 4,420,726
Free Cash Flow Per Share Twelve Trailing Months 0.11
Free Cash Flow Past Year 16,402,090
Free Cash Flow Prior Year 6,504,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating None

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD -0.44
MACD Signal -0.52
20-Day Bollinger Lower Band 11.02
20-Day Bollinger Middle Band 14.07
20-Day Bollinger Upper Band 17.11
Beta 0.10
RSI 44.60
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.00

System

Modified 10/29/2026 8:05:38 PM EST